Stress Ulcer Prophylaxis in Intensive Care Patients: An Evidence-Practice Mismatch?
- 1 February 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Critical Care Nursing Quarterly
- Vol. 22 (4) , 39-46
- https://doi.org/10.1097/00002727-200002000-00005
Abstract
Prophylactic drugs are commonly used in intensive care units (ICUs) to decrease the risk of development of stress-related upper gastrointestinal tract lesions and bleeding. The aim of this article is to discuss history, incidence, risk factors, past and current research, and current evidence for usefulness of prophylaxis for this disorder. Currently, very good evidence suggests that most ICU patients do not benefit from the widespread application of prophylactic intervention.Keywords
This publication has 8 references indexed in Scilit:
- National survey of stress ulcer prophylaxisCritical Care Medicine, 1999
- A Comparison of Sucralfate and Ranitidine for the Prevention of Upper Gastrointestinal Bleeding in Patients Requiring Mechanical VentilationNew England Journal of Medicine, 1998
- Prophylaxis for Stress-related Gastric Hemorrhage in the Medical Intensive Care UnitAnnals of Internal Medicine, 1994
- Changing Perspectives of Stress Gastritis ProphylaxisAnnals of Pharmacotherapy, 1994
- Risk Factors for Gastrointestinal Bleeding in Critically Ill PatientsNew England Journal of Medicine, 1994
- Nosocomial Pneumonia in Intubated Patients Given Sucralfate as Compared with Antacids or Histamine Type 2 BlockersNew England Journal of Medicine, 1987
- Enteral alimentation and gastrointestinal bleeding in mechanically ventilated patientsCritical Care Medicine, 1983
- Antacid Titration in the Prevention of Acute Gastrointestinal BleedingNew England Journal of Medicine, 1978